Hum. Reprod. Advance Access published online on October 24, 2006
Human Reproduction, doi:10.1093/humrep/del419
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Obstetrics and Gynecology, Hospital Universitario Dr Peset, Valencia, Spain
* To whom correspondence should be addressed. BACKGROUND: There is a need for a reliable marker of endometriosis, especially in early stages of peritoneal disease during which imaging is not effective. The use of serum interleukin (IL)-6 as a marker is controversial. To readdress the matter, patients undergoing laparoscopy were prospectively evaluated for serum IL-6 levels. MATERIALS AND METHODS: A total of 119 women 31 years old who underwent laparoscopy were divided into groups: control patients (n = 38) with no pathologic findings; endometriosis sufferers (n = 47) with minimal-mild (MM, n = 11) or moderate-severe (MS, n = 36) endometriosis; uterine myomas (n = 13) and benign ovarian pathologies (n = 21). Blood was drawn on cycles days 5-12 and stored for subsequent analysis of IL-6 and carbohydrate antigen (CA)-125 levels. RESULTS: Serum IL-6 levels were significantly (P = 0.002) higher in women with MM endometriosis (29.4 ± 9.0 pg/ml) than in controls (15.7 ± 9.3 pg/ml). When all the non-endometriosis patients were grouped together (n = 72) and serum IL-6 (17.8 ± 12.1 pg/ml) compared with MS (n = 36; 17.6 ± 10.3 pg/ml) and MM (n = 11; 29.4 ± 9.0 pg/ml) endometriosis significantly (P < 0.01) higher levels in MM endometriosis were observed as compared to the other two groups. Serum Ca-125 levels were significantly (P < 0.01) elevated in MS endometriosis. A serum IL-6 threshold of 25.75 pg/ml afforded a sensitivity of 75% and specificity of 83% in the diagnosis of MM endometriosis. Sensitivity and specificity for CA-125 in the diagnosis of MS endometriosis, using 35 IU/ml as the cut-off value, were 47% and 97%, respectively. CONCLUSIONS: IL-6 is a reliable non-invasive marker of MM endometriosis, whereas Ca-125 is of use as a marker of severe cases.
Received April 7, 2006
Revised July 21, 2006
Accepted September 27, 2006
Article
Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis
S. Martínez 1, N. Garrido 2, J.L. Coperias 3, F. Pardo 1, J. Desco 1, J.A. García-Velasco 4, C. Simón 2, and A. Pellicer 5 *
2 Instituto Universitario Valenciano de Infertilidad (IVI), University of Valencia, Valencia, Spain
3 Servicio de Laboratorio, Hospital Santa Barbara, Puertollano, Ciudad Real, Spain
4 IVI-Madrid, Rey Juan Carlos University, Madrid, Spain
5 Department of Obstetrics and Gynecology, Hospital Universitario Dr Peset, Valencia, Spain; Instituto Universitario Valenciano de Infertilidad (IVI), University of Valencia, Valencia, Spain
A. Pellicer, E-mail: pellicer_ant{at}gva.es
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Akkaya, G. Onalan, N. Haberal, N. Bayraktar, B. Mulayim, and H. B. Zeyneloglu Doxycycline causes regression of endometriotic implants: a rat model Hum. Reprod., August 1, 2009; 24(8): 1900 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, D. G. de Matos, H.-Y. Fan, M. Shimada, S. Palmer, and J. S. Richards Interleukin-6: An Autocrine Regulator of the Mouse Cumulus Cell-Oocyte Complex Expansion Process Endocrinology, July 1, 2009; 150(7): 3360 - 3368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ponce, M. Torres, C. Galleguillos, H. Sovino, M A. Boric, A. Fuentes, and M C. Johnson Nuclear factor {kappa}B pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis Reproduction, April 1, 2009; 137(4): 727 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Y. Fujii, M. Nakayama, and A. Nakagawa Concentrations of Receptor for Advanced Glycation End Products, VEGF and CML in Plasma, Follicular Fluid, and Peritoneal Fluid in Women With and Without Endometriosis Reproductive Sciences, December 1, 2008; 15(10): 1066 - 1074. [Abstract] [PDF]
|
|